Can a diabetes drug boost heart fuel? new study investigates

NCT ID NCT06229678

Recruiting now Knowledge-focused Sponsor: The University of Texas Health Science Center at San Antonio Source: ClinicalTrials.gov ↗

First seen Feb 05, 2026 · Last updated May 14, 2026 · Updated 16 times

Summary

This study looks at how a common diabetes medication (SGLT2 inhibitor) changes energy levels in the heart muscle. Researchers will measure key energy molecules in the heart before and after treatment. The goal is to understand if this drug helps the heart work better in people with type 2 diabetes and heart failure. About 71 adults aged 18-80 with these conditions will take part.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEART FAILURE WITH REDUCED EJECTION FRACTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Texas Diabetes Institute - University Health System
RECRUITING

San Antonio, Texas, 78207, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact

Contact

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact

Conditions

Explore the condition pages connected to this study.

HEART FAILURE WITH REDUCED EJECTION FRACTION TYPE2DIABETES TYPE2DIABETES